Literature DB >> 32172170

Weight gain in early, mid, and late pregnancy and hypertensive disorders of pregnancy.

Annie M Dude1, Michelle A Kominiarek2, David M Haas3, Jay Iams4, Brian M Mercer5, Samuel Parry6, Uma M Reddy7, George Saade8, Robert M Silver9, Hyagriv Simhan10, Ronald Wapner11, Deborah Wing12, William Grobman2.   

Abstract

OBJECTIVE: To examine the relationship of weight change during early, mid, and late pregnancy with the development of a hypertensive disorder of pregnancy (HDP). STUDY
DESIGN: These data are from a prospective cohort study of nulliparous women with live singleton pregnancies. "Early" weight change was defined as the difference between self-reported pre-pregnancy weight and weight at the first visit (between 6 and 13 weeks' gestation); "mid" weight change was defined as the weight change between the first and second visits (between 16 and 21 weeks' gestation); "late" weight change was defined as the weight change between the second and third visits (between 22 and 29 weeks' gestation). Weight change in each time period was further characterized as inadequate, adequate, or excessive based on the Institute of Medicine's (IOM's) trimester-specific weekly weight gain goals based on pre-pregnancy body mass index. Multivariable Poisson regression was performed to adjust for potential confounders. MAIN OUTCOME MEASURE: Development of any hypertensive disorder of pregnancy.
RESULTS: Of 8296 women, 1564 (18.9%) developed a HDP. Weight gain in excess of the IOM recommendations during the latter two time periods was significantly associated with HDP. Specifically, trimester-specific excessive weight gain in the mid period (aIRR 1.16, 95% CI 1.01-1.35) as well as in the late period (aIRR = 1.19, 95% CI = 1.02-1.40) was associated with increased risk of developing HDP. The weight gain preceded the onset of clinically apparent disease.
CONCLUSIONS: Excessive weight gain as early as the early second trimester was associated with increased risks of development of HDP.
Copyright © 2020 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gestational weight gain; Hypertensive disorders; Preeclampsia; Pregnancy

Mesh:

Year:  2020        PMID: 32172170      PMCID: PMC7198322          DOI: 10.1016/j.preghy.2020.03.001

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  26 in total

1.  Interpregnancy weight change and risk for adverse perinatal outcome.

Authors:  Annick Bogaerts; Bea R H Van den Bergh; Lieveke Ameye; Ingrid Witters; Evelyne Martens; Dirk Timmerman; Roland Devlieger
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

2.  Exercise during pregnancy improves maternal health perception: a randomized controlled trial.

Authors:  Ruben Barakat; Mireia Pelaez; Rocio Montejo; Maria Luaces; Maria Zakynthinaki
Journal:  Am J Obstet Gynecol       Date:  2011-02-26       Impact factor: 8.661

3.  Pregnancy Weight Gain Before Diagnosis and Risk of Preeclampsia: A Population-Based Cohort Study in Nulliparous Women.

Authors:  Jennifer A Hutcheon; Olof Stephansson; Sven Cnattingius; Lisa M Bodnar; Anna-Karin Wikström; Kari Johansson
Journal:  Hypertension       Date:  2018-06-18       Impact factor: 10.190

4.  Pre-pregnancy body mass index and weight gain during pregnancy: relations with gestational diabetes and hypertension, and birth outcomes.

Authors:  B Heude; O Thiébaugeorges; V Goua; A Forhan; M Kaminski; B Foliguet; M Schweitzer; G Magnin; M A Charles
Journal:  Matern Child Health J       Date:  2012-02

5.  Adult Pre-pregnancy Weight Change and Risk of Developing Hypertensive Disorders in Pregnancy.

Authors:  Akilew A Adane; Gita D Mishra; Leigh R Tooth
Journal:  Paediatr Perinat Epidemiol       Date:  2017-04-07       Impact factor: 3.980

6.  Prepregnancy body mass index, gestational weight gain, and risk of hypertensive pregnancy among Latina women.

Authors:  Renée Turzanski Fortner; Penelope Pekow; Caren G Solomon; Glenn Markenson; Lisa Chasan-Taber
Journal:  Am J Obstet Gynecol       Date:  2008-12-13       Impact factor: 8.661

7.  Hypertensive disorders and severe obstetric morbidity in the United States.

Authors:  Elena V Kuklina; Carma Ayala; William M Callaghan
Journal:  Obstet Gynecol       Date:  2009-06       Impact factor: 7.661

8.  Association Between Gestational Weight Gain and Perinatal Outcomes.

Authors:  Michelle A Kominiarek; George Saade; Lisa Mele; Jennifer Bailit; Uma M Reddy; Ronald J Wapner; Michael W Varner; John M Thorp; Steve N Caritis; Mona Prasad; Alan T N Tita; Yoram Sorokin; Dwight J Rouse; Sean C Blackwell; Jorge E Tolosa
Journal:  Obstet Gynecol       Date:  2018-10       Impact factor: 7.661

9.  Gestational weight gain as a risk factor for hypertensive disorders of pregnancy.

Authors:  Corrie Macdonald-Wallis; Kate Tilling; Abigail Fraser; Scott M Nelson; Debbie A Lawlor
Journal:  Am J Obstet Gynecol       Date:  2013-05-24       Impact factor: 8.661

10.  Hypertension in pregnancy and risk of coronary heart disease and stroke: A prospective study in a large UK cohort.

Authors:  Dexter Canoy; Benjamin J Cairns; Angela Balkwill; F Lucy Wright; Asma Khalil; Valerie Beral; Jane Green; Gillian Reeves
Journal:  Int J Cardiol       Date:  2016-08-01       Impact factor: 4.164

View more
  2 in total

1.  Changes in Serum Levels of Ketone Bodies and Human Chorionic Gonadotropin during Pregnancy in Relation to the Neonatal Body Shape: A Retrospective Analysis.

Authors:  Kiwamu Noshiro; Takeshi Umazume; Rifumi Hattori; Soromon Kataoka; Takashi Yamada; Hidemichi Watari
Journal:  Nutrients       Date:  2022-05-09       Impact factor: 6.706

2.  Annual body mass index gain and risk of hypertensive disorders of pregnancy in a subsequent pregnancy.

Authors:  Sho Tano; Tomomi Kotani; Takafumi Ushida; Masato Yoshihara; Kenji Imai; Tomoko Nakano-Kobayashi; Yoshinori Moriyama; Yukako Iitani; Fumie Kinoshita; Shigeru Yoshida; Mamoru Yamashita; Yasuyuki Kishigami; Hidenori Oguchi; Hiroaki Kajiyama
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.